News · Brain & Mental Health
Statins after a type 2 diabetes diagnosis: starting early tied to 15% lower dementia risk
People with type 2 diabetes face a higher risk of dementia. In Danish national records of 132,585 people, those who began a statin within a year of diagnosis had modestly fewer dementia diagnoses over a decade.
- An observational study of 132,585 people in Denmark who developed type 2 diabetes from 2006 to 2019.
- None were taking a statin at diagnosis; the study compared starting early, starting late, or not starting.
- Estimated 10-year dementia risk was 3.3% with early statins, 3.5% with late and 3.9% with none.
- Early starters had about 15% lower relative risk, an absolute difference of 0.59 percentage points.
- Statin users may differ in other ways, and the authors call for trials to confirm the link.
Type 2 diabetes raises the risk of dementia, and there is still no treatment that reliably stops dementia once it starts. That has pushed attention toward prevention, and toward the risk factors that can be treated, such as high cholesterol.
A study in The Lancet Regional Health - Europe used Danish national records for 132,585 people newly diagnosed with type 2 diabetes. Those who started a statin within a year had a modestly lower risk of dementia over the following decade than those who did not start one.
What dementia is and why diabetes matters
MedlinePlus describes dementia as a loss of mental functions, such as thinking, memory, and reasoning, that is severe enough to interfere with a person’s daily functioning. It is not a single disease but a group of conditions with different causes.
Blood vessel damage is one of them, and diabetes accelerates it. The authors set out their reasoning: attention has turned to prevention through treatment of modifiable risk factors such as low-density lipoprotein cholesterol, the kind that statins lower.
How the Danish statin study worked
The researchers used national registers to find statin-naïve individuals in Denmark developing type 2 diabetes from 2006 through 2019, meaning none were taking a statin when diagnosed. They followed them to the end of 2021.
They compared three strategies: starting a statin within a year of diagnosis, starting between one and five years, or not starting within five years. To make the comparison fairer, they used a design that mimics a randomized trial, called target trial emulation, with statistical weighting to balance the groups.
What happened to dementia risk
Dementia was uncommon over the period, affecting 2.7% of people during a median of about seven years. The estimated 10-year risk was 3.9% for those who did not start a statin, 3.5% for late starters and 3.3% for early starters.
Compared with no statin, early statin treatment was associated with 15% lower dementia risk at 10 years, and late treatment with 10% lower. In absolute terms the differences were small: about six fewer dementia diagnoses per 1,000 people for early starters.
Why the timing of statins may matter
The finding that earlier starters did better than later starters fits the idea that protecting blood vessels sooner leaves less damage to accumulate, including in the brain. It also lines up with the broader case for treating cholesterol in diabetes, which is already recommended for heart and stroke protection.
The authors are measured about what it means. They conclude that statin therapy was associated with lower relative and absolute risks of dementia, most pronounced in those with early statin initiation, and state that there is a need for trial evidence to confirm the findings.
What a registry study of statins cannot prove
People who start statins promptly may differ from those who do not: they may see doctors more, follow advice more closely, or be healthier in ways records do not capture. The trial-like design reduces this problem but cannot remove it.
Dementia diagnoses in registers depend on people being assessed, and milder cases may be missed. The study was set in Denmark, with its particular health system and population. And the absolute differences are small, which leaves room for modest biases to matter.
What this changes for people with type 2 diabetes
For people newly diagnosed with type 2 diabetes, statins are already commonly recommended to protect the heart and prevent strokes. This study suggests there may be a small brain benefit too, and that starting earlier rather than later could matter.
That is a reason to discuss statins with a doctor at diagnosis rather than to take one purely for memory. The measures with the strongest evidence for protecting the brain in diabetes remain good blood sugar and blood pressure control, not smoking, and staying physically active.
People also ask
What did the study find?
Over a median 7.1 years, 2.7% developed dementia. Estimated 10-year absolute risks were 3.9% with no statin, 3.5% with late initiation (1 to 5 years) and 3.3% with early initiation (within 1 year). Early statins were associated with 15% lower relative risk (95% CI 9% to 21%) and late statins with 10% lower (3% to 15%); absolute differences were 0.59 and 0.38 percentage points.
Why would statins affect dementia?
Statins lower LDL cholesterol and reduce damage to blood vessels, including those supplying the brain. Vascular damage contributes to many cases of dementia, especially in people with diabetes.
What is a target trial emulation?
A way of analyzing health records as if they were a randomized trial, by setting out who is eligible, the strategies being compared and the outcomes in advance. It reduces some biases but cannot remove them all.
How big is a 0.59 percentage point difference?
Small for any individual: roughly six fewer dementia diagnoses per 1,000 people over ten years. Across a large population with diabetes, that could add up.
Are statins recommended in type 2 diabetes anyway?
Many guidelines already recommend statins for most adults with type 2 diabetes to lower heart attack and stroke risk. Any brain benefit would come on top of that.
Should I start a statin to protect my memory?
Not on this evidence alone. If you have type 2 diabetes, ask your doctor whether a statin is right for your heart risk. This is general information rather than medical advice.